Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Akari Therapeutics ADR (NQ: AKTX )

0.9400 -0.0599 (-5.99%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 104,286
Open 0.9999
Bid (Size) 0.1000 (100)
Ask (Size) 1.010 (1)
Prev. Close 0.9999
Today's Range 0.9100 - 0.9999
52wk Range 0.9000 - 1.880
Shares Outstanding 3,847,331,923
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Stocks That Hit 52-Week Lows On Monday
During Monday's session, 77 companies made new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Radius Health (NASDAQ:RDUS) stock moved upwards by 18.8% to $6.94 during Thursday's after-market session. The company's market cap stands at $330.1 million. 
Via Benzinga

Performance

YTD
-37.75%
-37.75%
1 Month
-20.34%
-20.34%
3 Month
-20.34%
-20.34%
6 Month
-37.33%
-37.33%
1 Year
-45.66%
-45.66%

More News

Read More
The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Akari Therapeutics' Nomacopan Secures Expediated Review Tag For Blistering Skin Disorder
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
25 Stocks Moving in Tuesday's Pre-Market Session
Via Benzinga
Akari Therapeutics' To Go With Pivotal Bullous Pemphigoid Study With Nomacopan
Via Benzinga
Exposures Product Safety
42 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.